Tempest Therapeutics, Inc. · NASDAQ:TPST
Matthew Angel reported a 37.40% stake in Tempest Therapeutics, Inc. (Schedule 13D/A)
Event Mar 24, 2026 · Filed Mar 25, 2026
Matthew Angel reported a 37.40% stake in Tempest Therapeutics, Inc., 5,531,516 shares, with active intent on Mar 24, 2026. Filed Mar 25, 2026 (Schedule 13D/A).
- Stake
- 37.40%
- Shares
- 5,531,516
- Intent
- Active
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Matthew Angel | 37.40% | 5,531,516 |